Cyclophosphamide treatment for refractory atypical Kawasaki disease with giant coronary aneurysms: a case report.

Yi, B Y; Pick, J; Votava-Smith, J; Reyhan, I; Wagner-Lees, S; Szmuszkovicz, J

Yi, B Y; Pick, J; Votava-Smith, J; Reyhan, I; Wagner-Lees, S; Szmuszkovicz, J.

Yi BY; Division of Rheumatology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Pick J; Division of Cardiology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Votava-Smith J; Division of Cardiology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Reyhan I; Division of Rheumatology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Wagner-Lees S; Division of Cardiology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Szmuszkovicz J; Division of Cardiology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA.

Scand J Rheumatol ; 51(5): 417-418, 2022 09.

Article in English | MEDLINE | ID: covidwho-2062500

Subject(s)

Coronary Aneurysm; Mucocutaneous Lymph Node Syndrome; Coronary Aneurysm/diagnostic imaging; Coronary Aneurysm/drug therapy; Coronary Aneurysm/etiology; Cyclophosphamide/therapeutic use; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syndrome/complications; Mucocutaneous Lymph Node Syndrome/drug therapy; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronary Aneurysm / Mucocutaneous Lymph Node Syndrome Type of study: Case report / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Scand J Rheumatol Year: 2022 Document Type: Article Affiliation country: 03009742.2022.2031282

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google